Hardly a surprise, this line of credit has been available for 8 months, the fact that they are willing to provide the money for shares is reasonably positive when taken at face value.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025